CollPlant Biotechnologies Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by CollPlant Holdings Ltd. (also referred to as CollPlant Biotechnologies Ltd.) on June 19, 2018. The registrant is a foreign private issuer based in Ness Ziona, Israel, and files annual reports on Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose a corporate governance update and does not contain financial statements or performance data.
Material Changes
The material change disclosed in this filing is the appointment of Professor Shay Soker from the Wake Forest Institute for Regenerative Medicine to the company's Scientific Advisory Board.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook, management commentary on operations, or specific risk factors. The primary content is the press release regarding the new advisory board appointment.
Key Facts for Investor Verification
- Professor Shay Soker has been appointed to the Scientific Advisory Board.
- Professor Soker is affiliated with the Wake Forest Institute for Regenerative Medicine.
- The filing contains no financial results or operational metrics for the period.
- The report was signed by Eran Rotem, Deputy CEO and Chief Financial Officer.